• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤连蛋白与皮肤穿通性疾病中的细胞外基质

Fibronectin and the extracellular matrix in the perforating disorders of the skin.

作者信息

Morgan M B, Truitt C A, Taira J, Somach S, Pitha J V, Everett M A

机构信息

Department of Pathology: University of South Florida Health Science Center, James A. Haley Veteran's Hospital, Tampa, USA.

出版信息

Am J Dermatopathol. 1998 Apr;20(2):147-54. doi: 10.1097/00000372-199804000-00008.

DOI:10.1097/00000372-199804000-00008
PMID:9557783
Abstract

Despite detailed microscopic descriptions and clinical observation, little is known regarding the pathogenesis of the perforating disorders of skin, which have traditionally been subdivided into numerous microscopic entities associated with various clinical settings. An increasing body of evidence now suggests that the perforating disorders of skin are akin, and may constitute an expanded single pathologic entity. Each of the classic perforating disorders of skin, including elastosis perforans serpiginosa, perforating folliculitis, reactive perforating collagenosis, Kyrle's disease, and perforating disorder of uremia, have been shown to extrude collagen, elastin, and related extracellular matrix components through the epidermis. Considering a shared pathogenic mechanism among these entities, we explored the possible role of the extracellular matrix, in particular fibronectin, in perforating disorders of skin. Using immunohistochemical and serum determinations of extracellular matrix constituents, including fibronectin, collagen type IV, laminin, and tenascin, we showed consistent serum elevation and/or deposition of fibronectin, in each case, without a commensurate increase in laminin, collagen type IV, and tenascin. We propose that elevated serum and tissue concentrations of fibronectin may be responsible for inciting, in a physiologically aberrant manner, increased epithelial migration and proliferation culminating in perforation.

摘要

尽管有详细的微观描述和临床观察,但对于皮肤穿通性疾病的发病机制仍知之甚少,这些疾病传统上被细分为与各种临床情况相关的众多微观实体。现在越来越多的证据表明,皮肤穿通性疾病具有相似性,可能构成一个扩展的单一病理实体。每种经典的皮肤穿通性疾病,包括匐行性穿通性弹力纤维病、穿通性毛囊炎、反应性穿通性胶原病、 Kyrle病和尿毒症性穿通性疾病,都已被证明可通过表皮排出胶原蛋白、弹性蛋白和相关的细胞外基质成分。考虑到这些实体之间存在共同的致病机制,我们探讨了细胞外基质,特别是纤连蛋白,在皮肤穿通性疾病中的可能作用。通过免疫组织化学和对包括纤连蛋白、IV型胶原、层粘连蛋白和腱生蛋白在内的细胞外基质成分进行血清检测,我们发现每种情况下纤连蛋白的血清水平均持续升高和/或沉积,而层粘连蛋白、IV型胶原和腱生蛋白却没有相应增加。我们认为,血清和组织中纤连蛋白浓度升高可能以生理异常的方式,促使上皮细胞迁移和增殖增加,最终导致穿孔。

相似文献

1
Fibronectin and the extracellular matrix in the perforating disorders of the skin.纤连蛋白与皮肤穿通性疾病中的细胞外基质
Am J Dermatopathol. 1998 Apr;20(2):147-54. doi: 10.1097/00000372-199804000-00008.
2
Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers.获得性穿通性皮肤病。胶原蛋白和弹性纤维经表皮联合清除的证据。
Arch Dermatol. 1989 Aug;125(8):1074-8. doi: 10.1001/archderm.125.8.1074.
3
Expression of the 67-kDa elastin receptor in perforating skin disorders.67-kDa弹性蛋白受体在穿通性皮肤病中的表达。
Br J Dermatol. 2002 Jan;146(1):74-9. doi: 10.1046/j.1365-2133.2002.04550.x.
4
Perforating disorders of the skin.皮肤穿孔性疾病
Indian J Pathol Microbiol. 2013 Oct-Dec;56(4):355-8. doi: 10.4103/0377-4929.125289.
5
Acquired perforating dermatosis: clinicopathological features in twenty-two cases.获得性穿通性皮肤病:22例临床病理特征
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88. doi: 10.1111/j.1468-3083.2006.01571.x.
6
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.细胞外基质成分腱糖蛋白、纤连蛋白、IV型胶原和层粘连蛋白在乳腺癌中的免疫组化表达:它们的预后价值以及在肿瘤侵袭和进展中的作用
Eur J Cancer. 2002 Dec;38(18):2362-70. doi: 10.1016/s0959-8049(02)00210-1.
7
Clinical practice guide for the treatment of perforating dermatosis.穿孔性皮肤病治疗临床实践指南。
J Dermatol. 2020 Dec;47(12):1374-1382. doi: 10.1111/1346-8138.15647. Epub 2020 Oct 23.
8
The perforating disorders.穿孔性疾病。
J Am Acad Dermatol. 1984 Apr;10(4):561-81. doi: 10.1016/s0190-9622(84)80259-5.
9
A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.尿路上皮癌中细胞外基质成分表达的临床病理研究
BJU Int. 2005 Mar;95(4):655-9. doi: 10.1111/j.1464-410X.2005.05357.x.
10
Perforating dermatoses: a review and report of four cases.穿通性皮肤病:病例回顾及4例报告
J Dermatol. 1993 Jun;20(6):329-40. doi: 10.1111/j.1346-8138.1993.tb01294.x.

引用本文的文献

1
Successful management of a severe case of chronic giant acquired reactive perforating collagenosis with allopurinol.用别嘌醇成功治疗一例严重慢性巨块型获得性反应性穿通性胶原病
JAAD Case Rep. 2023 Aug 14;40:99-102. doi: 10.1016/j.jdcr.2023.07.040. eCollection 2023 Oct.
2
Acquired Reactive Perforating Collagenosis: Case Series.获得性反应性穿通性胶原病:病例系列
Indian Dermatol Online J. 2022 Dec 29;14(1):72-76. doi: 10.4103/idoj.idoj_373_22. eCollection 2023 Jan-Feb.
3
Novel insights into PORCN mutations, associated phenotypes and pathophysiological aspects.
对 PORCN 突变、相关表型和病理生理方面的新认识。
Orphanet J Rare Dis. 2022 Jan 31;17(1):29. doi: 10.1186/s13023-021-02068-w.
4
Kyrle's disease in a patient of diabetes mellitus and chronic renal failure on dialysis.一名接受透析治疗的糖尿病和慢性肾衰竭患者患凯尔氏病。
J Family Med Prim Care. 2015 Apr-Jun;4(2):284-6. doi: 10.4103/2249-4863.154678.
5
Familial reactive perforating collagenosis: a report of two cases.家族性反应性穿通性胶原病:两例报告。
Indian J Dermatol. 2014 May;59(3):287-9. doi: 10.4103/0019-5154.131405.
6
Familial reactive perforating collagenosis.家族性反应性穿通性胶原病
Indian J Dermatol. 2009;54(4):334-7. doi: 10.4103/0019-5154.57608.